CNBC: Investing
OCTOBER 22, 2023
Piper Sandler analyst Allison Bratzel said the loss of lean muscle while taking GLP-1 drugs is "a major shortcoming" that could have bigger consequences.
Global Newswire by Notified: M&A
OCTOBER 22, 2023
BASEL, Switzerland and LONDON and NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) announced today the entry into a definitive agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY) to acquire Telavant Holdings, Inc. (Telavant), a Roivant company, owned by Roivant Sciences Ltd. and Pfizer Inc. The agreement includes the development, manufacturing and commercialization rights in the US and Japan for RVT-3101, a novel TL1A directed antibody.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CNBC: Investing
OCTOBER 22, 2023
TipRanks' analyst ranking service pinpoints Wall Street's best-performing stocks, including Cisco and Chesapeake Energy.
Global Newswire by Notified: M&A
OCTOBER 22, 2023
Textainer Shareholders to Receive $50.00 Per Share in Cash Textainer Shareholders to Receive $50.
Advertisement
Generative AI is upending the way product developers & end-users alike are interacting with data. Despite the potential of AI, many are left with questions about the future of product development: How will AI impact my business and contribute to its success? What can product managers and developers expect in the future with the widespread adoption of AI?
CNBC: Investing
OCTOBER 22, 2023
The Oracle of Omaha famously believes cryptocurrencies are highly speculative, non-productive assets.
How2Exit
OCTOBER 22, 2023
b' E151: Della Kirkman, CPA interviews They Got Acquired Founder, Alexis Grant, Shares Insights on Building and Selling Online Businesses - Watch Here rn rn Here is what my team and I learned from this interview: (These are notes from team members, writers, sometimes AI, and even listeners who submitted what i learned loosely edited and shared here) - If it seems a bit unrefined, you're reading our notes, so. yeah.
Expert insights. Personalized for you.
123 
Let's personalize your content